Prof. Dr. med. Frank Gansauge

Prof. Dr. med. Frank Gansauge
(c) LDG Laboratories Dr. Gansauge GmbH

Prof. Dr. med. Frank Gansauge is the Director of the LDG Laboratories Dr. Gansauge Berg, and the Head Physician of the Department of Oncology and Dendritic Cell Therapy at this clinic.

Prof. Gansauge graduated from the Faculty of Medicine at the University of Tuebingen (Germany), and he also trained in Cardiff (UK). After his work at the University Hospital Ulm and habilitation at the University of Ulm, the professor focused on immunology and cancer treatment. In 2001, he founded the LDG Laboratories Dr. Gansauge Berg.

The clinic's unique offer is LANEX-DC® dendritic cell immunotherapy for cancer. Prof. Gansauge is one of the most experienced specialists in the field of dendritic cell therapy worldwide. LANEX-DC® dendritic cell immunotherapy is an innovative last-line treatment. Dendritic cells can significantly prolong the lives of patients who have already undergone all standard treatments.

Prof. Gansauge is the author of more than 160 scientific publications and numerous book chapters. He has also repeatedly won prestigious awards, including the Fred Stephans Award and the Merkle Research Award. He is also a Visiting Professor at Liaoning University of Technology in China, a Visiting Professor at the Faculty of Medicine of the University of Belgrade in Serbia, and a Professor at Shanxi Medical University in China.

Place of work: LDG Laboratories Dr. Gansauge GmbH


Interview with the professor